K Ito

No ORCID on file · 6 papers in corpus · active 1981-1998

Study types

  • article 6

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
article 1998
Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT)
European journal of cancer (Oxford, England : 1990) ·doi:10.1016/s0959-8049(97)10079-x
article 1994
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Gan to kagaku ryoho. Cancer & chemotherapy

We examined GAT, a newly developed tumor marker, in serum samples collected from 1,503 females in six institutions: 387 healthy females, 1,052 patients with gynecological diseases including 311 ovarian cancers, and 64 with nongynecological …

article 1994
[Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Gan to kagaku ryoho. Cancer & chemotherapy

Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and CA602 with the respective EIA kits for assessment of their utility as tumor markers. A total of 5236 patients were…

article 1994
[The importance of CA125 immunohistochemical staining in patients with ovarian cancer].
Nihon Sanka Fujinka Gakkai zasshi

UNLABELLED: CA125 has been regarded as a marker for hyperplastic conditions, such as endometriosis or infectious peritonitis. A high serum CA125 level should therefore be carefully evaluated clinically. We measured CA125 levels in sera and …

article 1993
[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Gan to kagaku ryoho. Cancer & chemotherapy

Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of GAT were compared, the cut-off level of 16 U/ml (which corresponds to mean + 2SD among healthy females) was foun…

article 1981
Prostaglandins and dysmenorrhea effect of neproxen on prostaglandin concentrations in menstrual blood